Yule Catto & Co PLC
14 December 2005
Yule Catto & Co plc
Pre-close Trading Statement
Trading conditions for the Group in the second half of the year remain similar
to that indicated in the interim statement, with results anticipated to be
broadly in line with market expectations.
Polymer Chemicals continue to face high raw material costs, but the benefit of
good volume and somewhat better prices has enabled operating margins to move
forward. Unit sales of pharmaceutical active ingredients have been solid, but
with no new major product launches, the normal pricing erosion of our generic
products has impacted profitability.
On 7th December 2005, we confirmed the sale of Autoclenz Limited, the latest
transaction involved in the reshaping of Performance Chemicals. To date, this
process has delivered gross proceeds of £22 million and further restructuring is
anticipated.
14 December 2005
ENQUIRIES:
YULE CATTO Tel: 01279 442791
Alex Walker, Chief Executive
Sean Cummins, Finance Director
COLLEGE HILL Tel: 020 7457 2020
Gareth David
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.